| Id: | acc4856 |
| Group: | 1sens |
| Protein: | CaMKII |
| Gene Symbol: | Camk2a |
| Protein Id: | P11798 |
| Protein Name: | KCC2A_MOUSE |
| PTM: | phosphorylation |
| Site: | Thr287 |
| Site Sequence: | ASCMHRQETVDCLKKFNARRK |
| Disease Category: | Endocrine and metabolic diseases |
| Disease: | Diabetes Mellitus |
| Disease Subtype: | ventricular arrhythmia |
| Disease Cellline: | |
| Disease Info: | |
| Drug: | EMPA |
| Drug Info: | "EMPA is a drug that may have specific therapeutic effects, though detailed information depends on its full context. " |
| Effect: | modulate |
| Effect Info: | "EMPA treatment significantly reduced premature ventricular complexes (PVCs) in db/db mice, improved calcium ion handling, inhibited the autophosphorylation of calmodulin-dependent protein kinase II (CaMKII) and the phosphorylation of RyR2, and simultaneously reduced the global O–GlcNAcylation level." |
| Note: | |
| Score: | 4.0 |
| Pubmed(PMID): | 36607794 |
| Sentence Index: | 36607794_8 |
| Sentence: | "Thr287 autophosphorylation and CaMKII-dependent RyR2 phosphorylation (S2814) were significantly increased in diabetic hearts, which were inhibited by EMPA." |
Sequence & Structure:
MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTTMLATRNFSGGKSGGNKKNDGVKESSESTNTTIEDEDTKVRKQEIIKVTEQLIEAISNGDFESYTKMCDPGMTAFEPEALGNLVEGLDFHRFYFENLWSRNSKPVHTTILNPHIHLMGDESACIAYIRITQYLDAGGIPRTAQSEETRVWHRRDGKWQIVHFHRSGAPSVLPH
Select PDB:
No data.
Protein Tractability:
source: Open TargetsNo data.
PTM Intensity:
source: CPTACNo data.
PTM-Disease Association:
source: PTMDNo data.
PTM-Drug Perturbation Response:
source: DecryptMNo data.
Function score:
source: funscoRNo data.
